AbSci will attend BioEurope Spring – March 25–27, 2019
European friends, if you have an interest in learning more about AbSci’s expression platform, SoluPro. Or would like to hear about AbSci’s novel 12-week cell line optimization workflow, reach out to Kole Krieger to schedule a meeting....AbSci to Attend BPI-West 2019
If you have an interest in learning more about AbSci’s expression platform, SoluPro, or would like to hear about AbSci’s novel 12-week cell line optimization workflow, reach out to Kole Krieger to schedule some time to meet. kkrieger@abscibio.com...
AbSci Establishes New Collaboration with Sanofi
“This collaboration illustrates the need for new expression technologies that are capable of producing these next-generation antibody and protein scaffolds. We’ve shown SoluProTM can uniquely deliver on this industry need.”
AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board
“It is rejuvenating to be working with a young and energetic company like AbSci. Their exciting technology not only has dramatic development, yield and production speed advantages for manufacture of complex biopharmaceuticals,” – Andrew J.S. Jones, D. Phil